EXPECTATIONS OF PREVENTIVE BENEFITS & HIV-RELATED RISK BEHAVIORS IN HPTN069/ACTG5305
When clinical trial participants hold a preventive misconception (PM), i.e., expectations that experimental interventions will confer protection from HIV infection, they may engage in behaviors possibly increasing their risk of acquiring HIV. We evaluated these issues in HPTN069/ACTG A5305 [NCT01505114], a double-blind, phase 2 study that compared 4 potential preexposure prophylaxis (PrEP) regimens: maraviroc (MVC);…